<DOC>
	<DOCNO>NCT00438113</DOCNO>
	<brief_summary>Atrial fibrillation ( AF ) common arrhythmia cause many symptom result numerous hospitalization . Catheter ablation technique evolve significantly improve symptomatic recurrence , offer 100 % cure rate . We hypothesize use aggressive BP lower reduce rate recurrent AF catheter ablation AF . We plan randomize clinical trial aggressive BP lower versus standard BP control investigate .</brief_summary>
	<brief_title>Atrial Substrate Modification With Aggressive Blood Pressure Lowering Prevent AF</brief_title>
	<detailed_description>Background : Atrial fibrillation ( AF ) common sustain arrhythmia associate significant morbidity , necessitate treatment . Radiofrequency ablation atrial fibrillation/flutter evolve significantly close come 'cure ' dysrhythmias . Recurrence atrial fibrillation undergone radiofrequency ablation treatment AF 40 % one year higher persistent AF . Hypertension potent risk factor AF , recent study demonstrate even modest increase BP may lead high incidence AF . There clinical trial evidence date investigate aggressive BP control patient post radiofrequency ablation AF prevent recurrent AF . Objective : We propose determine aggressive BP control reduce recurrent AF post ablation . Hypothesis : Aggressive BP lower reduce incidence recurrent AF post ablation . Research Plan : Study Design . This randomized open label trial patient post catheter ablation atrial fibrillation . Randomization either aggressive BP lower standard BP control occur three six month prior procedure . Study Population . Patients include persistent high burden paroxysmal ( refractory class 1 3 antiarrhythmic medication ) intend catheter ablation procedure AF . Followup . Patients follow 3 month interval first year , every 6 month maximum 30 month common study end date reach ( 1 year post randomization last patient enrol ) . Statistical Analysis . Kaplan-Meier analysis primary outcome perform . A Cox proportional hazard model construct assess effect variable choose priori primary outcome .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Quinapril</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Terazosin</mesh_term>
	<criteria>Documented systolic blood pressure great equal 130 mmHg Undergoing plan catheter ablation persistent AF ( last &gt; 7 day &lt; 365 day require electrical chemical cardioversion ) OR High burden paroxysmal AF &gt; 6 month ( great equal 3 symptomatic episdes past 6 month refractory inteolerant least 1 class 1 3 antiarrhythmic ) Permanent atrial fibrillation Contraindication Accupril ACEI Women childbearing potential Life expectancy less 1 year Less 18 year age Unable give inform consent Known moderate several renal dysfunction ( eGFR &lt; 30 ml/min/1.73m2 ) Prior AF catheter ablation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>blood pressure</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>catheter ablation</keyword>
</DOC>